Clinic
Central Texas Community Health Centers
Central Texas Community Health Centers was paid $28.72M by Medicaid between Oct 2019 and Dec 2024, across 130 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 60% of everything it billed.
33Billing provider infoCENTRAL TEXAS COMMUNITY HEALTH CENTERS
AUSTIN, TX 78723
AUSTIN, TX 78723
33aNPI1790326171assigned 10/07/2019
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$28.72M
24GClaims443,690
24DCodes billed130
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Texas
Rank by total paid#6 of 248
Median peer was paid$796K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SLOAN, JOY controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 5,457 | $368K | |
| 2020 | 34,424 | $2.15M | |
| 2021 | 102,437 | $6.03M | |
| 2022 | 111,108 | $6.89M | |
| 2023 | 95,858 | $6.66M | |
| 2024incomplete | 94,406 | $6.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 60% | 80,120 | 65,368 | $17.23M |
| D0999 | Unspecified diagnostic procedure, by report | 16% | 17,740 | 17,067 | $4.47M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5.6% | 17,911 | 4,904 | $1.61M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.8% | 8,696 | 2,613 | $813K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 18,821 | 17,068 | $712K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.2% | 22,968 | 20,630 | $646K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.0% | 8,436 | 8,120 | $571K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.9% | 6,674 | 6,442 | $535K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 7,743 | 7,449 | $463K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.3% | 6,813 | 6,564 | $380K |
| 87428 | 1.0% | 10,852 | 10,046 | $291K | |
| 99381 | <1% | 1,627 | 1,565 | $218K |
118 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,362 | $106K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,496 | $82K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 13,047 | $57K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,842 | $55K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,404 | $51K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,264 | $50K |
| S9152 | Speech therapy, re-evaluation | <1% | 466 | $50K |
| 99384 | <1% | 619 | $47K | |
| 92523 | <1% | 276 | $41K | |
| 99383 | <1% | 599 | $38K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,717 | $24K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 342 | $24K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,826 | $20K |
| 0071A | <1% | 584 | $16K | |
| 90461 | <1% | 2,923 | $10K | |
| 0072A | <1% | 240 | $8K | |
| 99382 | <1% | 149 | $8K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 16,847 | $7K |
| 0051A | <1% | 179 | $5K | |
| D1120 | Dental cleaning, child | <1% | 9,653 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 200 | $4K |
| 0001A | <1% | 477 | $4K | |
| 0054A | <1% | 129 | $4K | |
| 90620 | <1% | 2,331 | $4K | |
| D0120 | Dental checkup, returning patient | <1% | 9,269 | $4K |
| 81002 | <1% | 2,152 | $4K | |
| 96160 | <1% | 2,161 | $3K | |
| 99429 | <1% | 121 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 298 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 756 | $3K |
| 0052A | <1% | 78 | $3K | |
| 90480 | <1% | 158 | $3K | |
| 97168 | <1% | 25 | $3K | |
| 0002A | <1% | 210 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 52 | $2K |
| 96380 | <1% | 325 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 11,111 | $2K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 3,255 | $2K |
| 0124A | <1% | 46 | $2K | |
| D0272 | Bitewings - two radiographic images | <1% | 5,551 | $2K |
| D1351 | Sealant - per tooth | <1% | 7,893 | $1K |
| D0240 | <1% | 12,994 | $1K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 17,975 | $1K |
| 0081A | <1% | 40 | $1K | |
| D1110 | Prophylaxis - adult | <1% | 1,868 | $823.20 |
| 90619 | <1% | 1,481 | $822.47 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $800.00 |
| 97161 | <1% | 16 | $697.14 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 196 | $654.51 |
| 81025 | <1% | 137 | $522.41 | |
| D0274 | Bitewings - four radiographic images | <1% | 1,287 | $484.54 |
| 96158 | <1% | 110 | $431.98 | |
| 92551 | <1% | 1,470 | $177.91 | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 120 | $124.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $119.60 |
| 90474 | <1% | 1,788 | $105.30 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 466 | $87.92 |
| J3535 | Drug administered through a metered dose inhaler | <1% | 21 | $42.00 |
| D0140 | Limited oral evaluation - problem focused | <1% | 195 | $37.56 |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 804 | $35.32 |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | <1% | 553 | $27.11 |
| A9150 | Non-prescription drugs | <1% | 37 | $20.50 |
| 81003 | <1% | 148 | $15.51 | |
| 90686 | <1% | 10,281 | $7.61 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 20 | $7.58 |
| D0603 | <1% | 11,227 | $0.02 | |
| D0601 | <1% | 787 | $0.02 | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 34 | $0.01 |
| 90651 | 0% | 3,776 | $0.00 | |
| 91307 | 0% | 1,004 | $0.00 | |
| 90696 | 0% | 1,179 | $0.00 | |
| 90723 | 0% | 2,871 | $0.00 | |
| 90744 | 0% | 1,203 | $0.00 | |
| 90698 | 0% | 1,918 | $0.00 | |
| D0602 | 0% | 1,788 | $0.00 | |
| 96161 | 0% | 15 | $0.00 | |
| 90677 | 0% | 1,395 | $0.00 | |
| 90716 | 0% | 1,505 | $0.00 | |
| 90381 | 0% | 211 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 1,428 | $0.00 |
| 91305 | 0% | 650 | $0.00 | |
| 36416 | 0% | 439 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 221 | $0.00 |
| 90656 | 0% | 998 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 32 | $0.00 |
| D0210 | Intraoral - complete series of radiographic images | 0% | 30 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 84 | $0.00 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 0% | 172 | $0.00 |
| D1208 | Topical application of fluoride, excluding varnish | 0% | 142 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 17 | $0.00 |
| D7140 | Extraction, erupted tooth or exposed root | 0% | 29 | $0.00 |
| 91319 | 0% | 25 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
| 90633 | 0% | 3,295 | $0.00 | |
| 99173 | 0% | 2,334 | $0.00 | |
| 90681 | 0% | 2,874 | $0.00 | |
| 90648 | 0% | 4,039 | $0.00 | |
| 90710 | 0% | 1,272 | $0.00 | |
| 90734 | 0% | 1,719 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,580 | $0.00 |
| 90670 | 0% | 3,395 | $0.00 | |
| 90700 | 0% | 1,115 | $0.00 | |
| 90671 | 0% | 1,371 | $0.00 | |
| 90715 | 0% | 1,804 | $0.00 | |
| 91300 | 0% | 739 | $0.00 | |
| D1354 | 0% | 1,930 | $0.00 | |
| 90707 | 0% | 1,421 | $0.00 | |
| 91320 | 0% | 26 | $0.00 | |
| 99080 | 0% | 27 | $0.00 | |
| 91308 | 0% | 81 | $0.00 | |
| 91312 | 0% | 46 | $0.00 | |
| 90649 | 0% | 225 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 57 | $0.00 |
| 90655 | 0% | 53 | $0.00 | |
| D9910 | 0% | 87 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 42 | $0.00 |
| 90380 | 0% | 83 | $0.00 | |
| 94664 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSLOAN, JOY (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.